Molecular epidemiology of Candida africana isolates collected from vagina swabs in French Guiana (Équipe Seksik/Sokol)

March 07 - 2024

Jeanne Bigot, Yasmine Kalboussi, Yannick Bonkoto Nkoy, Alexis Benmostefa, Sandra Vellaissamy, Laurent Benzerara, Vincent Sainte-Rose, Denis Blanchet, Magalie Demar, Juliette Guitard, Christophe Hennequin

Med Mycol. 2024 Mar 7;62(3):myae016

Previous molecular studies have shown that Candida africana corresponds to the clade 13 of Candia albicans. It has been mostly involved in vulvovaginal candidiasis worldwide but few data exist in South America. The aim of our study was to investigate the prevalence of C. africana in women living in French Guiana. For this, we first set up a fluorescent-intercalating-dye-real time Polymerase Chain Reaction (PCR) targeting the hyphal wall protein 1 gene. The test was applied to 212 C. albicans isolates collected from May to August 2019 from vaginal swabs, allowing the identification of six women harboring C. africana (eight isolates). The in vitro susceptibility of these eight isolates to six antifungal drugs was also evaluated. No demographics or clinical-specific features could be demonstrated. Genetic diversity of those isolates was analyzed through multilocus sequence typing and showed that diploid sequence type 182 was predominant (n = 6) and allowed the report of a new diploid sequence type.
Candida africana, the clade 13 of C. albicans, is characterized by specific genetic and phenotypic traits. Using a new molecular technique, we report a high prevalence of C. africana in vaginal swabs from patients living in French Guiana. The worldwide predominant genotype was detected in all but one patient.

St. Antoine Hospital

Kourilsky Building
34 rue Crozatier - 75012 Paris

Sorbonne Université Medicine
Saint-Antoine Site
27 rue Chaligny - 75012 Paris

This site uses cookies and gives you control over what you want to enable Accept all Personalize